文献速递妇科

不同路径盆腔器官脱垂修复术后静脉血栓栓塞的发生率与危险因素

Incidence and risk factors for venous thromboembolism events after different routes of pelvic organ prolapse repairs.
PubMed 文献 · Am J Obstet Gynecol · 2020-05-13

基于美国外科医师学会国家手术质量改进计划2011-2017年数据,分析63,108例盆腔器官脱垂修复术,术后30天静脉血栓栓塞发生率为0.21%,腹部路径风险最高(0.72%),60%事件发生在术后10天内,腹部路径、手术时间、年龄、BMI、ASA 3/4级和术前肾衰竭为独立危险因素。

要点

  • 盆腔器官脱垂修复术后30天静脉血栓栓塞总体发生率低(0.21%)。
  • 腹部路径静脉血栓栓塞风险显著高于阴道路径(aOR 3.27)。
  • 超过60%的静脉血栓栓塞事件发生在术后10天内,应加强早期预防。

核心结论

  • 盆腔器官脱垂修复术后静脉血栓栓塞总体发生率很低,腹部路径风险最高,多数事件发生于术后10天内。

研究设计与样本

  • 回顾性队列研究,使用美国外科医师学会国家手术质量改进计划2011-2017年数据库,共分析63,108例盆腔器官脱垂修复术。

主要发现

  • 63,108例中133例发生静脉血栓栓塞(0.21%;95%CI 0.18-0.25;P<.0001)。
  • 阴道路径发生率为0.16%,腹腔镜路径为0.25%,腹部路径为0.72%。
  • 60%的静脉血栓栓塞事件发生在术后10天内。
  • 腹部路径 compared with 阴道路径的调整比值比为3.27(95%CI 1.93-5.41;P<.0001)。
  • 静脉血栓栓塞与30天死亡率、再入院和再手术相关(均P<.0001)。

关键数值与推荐

  • 年龄较大(P<.041)、BMI较高(P=.002)、种族/族裔(P=.04)、手术时间较长(P<.0001)、住院状态(P<.0001)、ASA 3或4级(P<.0001)、术前肾衰竭(P=.001)和慢性使用类固醇(P=.02)与静脉血栓栓塞显著相关。
  • 阴道路径组中,合并子宫切除术(P=.03)和术前呼吸困难(P=.01)与静脉血栓栓塞相关。
  • 腹部路径组中,合并子宫切除术(P=.005)和需药物治疗的高血压(P=.04)与静脉血栓栓塞独立相关。
  • 多因素调整后,腹部路径(aOR 3.27;95%CI 1.93-5.41;P<.0001)、手术时间较长(aOR 1.005;95%CI 1.003-1.006;P<.0001)、年龄较大(aOR 1.020;95%CI 1.00-1.037;P=.015)、BMI较高(aOR 1.04;95%CI 1.01-1.07;P=.0006)、ASA 3或4级(aOR 1.55;95%CI 1.03-2.31;P=.03)和术前肾衰竭(aOR 8.87;95%CI 1.16-44.15;P=.04)仍与静脉血栓栓塞显著相关。
  • 腹腔镜路径 compared with 阴道路径及合并手术(子宫切除术、抗尿失禁手术、阴道网片植入)与静脉血栓栓塞无显著关联。

临床怎么用

  • 应重点关注术后早期(尤其10天内)的血栓预防策略,尤其是腹部路径手术患者。
  • 对具有高龄、高BMI、ASA 3/4级、术前肾衰竭、慢性类固醇使用等危险因素的患者加强风险评估与预防。

局限性

  • 回顾性队列研究设计可能存在残余混杂。
  • 静脉血栓栓塞定义基于美国外科医师学会国家手术质量改进计划数据库,可能存在漏报或错分。
  • 研究人群以美国数据库为主,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous thromboembolism events, including deep venous thrombosis and pulmonary embolism are the most common cause of preventable deaths in hospitalized patients in the United States. Although the risk of venous thromboembolism events in benign gynecologic surgery is generally low, the potential for venous thromboembolism events in urogynecologic population is significant because most patients undergoing the pelvic organ prolapse surgery have increased surgical risk factors. OBJECTIVE: This study aimed to investigate the incidence and risk factors for venous thromboembolism events within 30 days after different routes of the pelvic organ prolapse surgery in a large cohort population using the American College of Surgeons-National Surgical Quality Improvement Program. STUDY DESIGN: This retrospective cohort study used Current Procedural Terminology codes to identify pelvic organ prolapse repairs with and without concurrent hysterectomy performed during 2011-2017 in the American College of Surgeons-National Surgical Quality Improvement Program database. Demographics, preoperative length of hospital stay, operative time, preoperative comorbidities, smoking status, American Society of Anesthesiologists classification system scores, along with other variables were collected. Postoperative 30-day complications, including readmission, reoperation, and mortality, were collected. The incidence rates of venous thromboembolism, as defined by American College of Surgeons-National Surgical Quality Improvement Program, were compared among different surgical routes. Descriptive statistics were used, and logistic regression was performed to identify associations. RESULTS: Among 91,480 pelvic organ prolapse surgeries identified, 63,108 were analyzed: 43,279 (68.6%) were performed vaginally, 16,518 (26.2%) laparoscopically, and 3311 (5.2%) abdominally. A total of 34,698 (55.0%) underwent a concurrent hysterectomy. Of 63,108 subjects, 133 developed venous thromboembolism within 30 days after surgery (0.21%; 95% confidence interval, 0.18-0.25; P<.0001). More than half (60%) of venous thromboembolism events occurred within 10 days after surgery. For all surgical routes, older age (P<.041), higher body mass index (P=.002), race or ethnicity (P=.04), longer operating time (P<.0001), inpatient status (P<.0001), American Society of Anesthesiologists 3 or 4 (P<.0001), having preoperative renal failure (P=.001), and chronic steroid use (P=.02) were significantly associated with venous thromboembolism. In addition, in the vaginal pelvic organ prolapse repair group, concurrent hysterectomy (P=.03) and preoperative dyspnea (P=.01) were associated with development of venous thromboembolism. In the abdominal pelvic organ prolapse repair, concurrent hysterectomy (P=.005) and hypertension requiring medication (P=.04) were also independently associated with venous thromboembolism development (Table 1). The incidence of venous thromboembolism was highest in abdominal repairs (0.72%), followed by laparoscopic repairs (0.25%) and vaginal repairs (0.16%). After adjusting for confounders, abdominal compared with vaginal approach (adjusted odds ratio, 3.27; 95% confidence interval, 1.93-5.41; P<.0001), longer operative time (adjusted odds ratio, 1.005; 95% confidence interval, 1.003-1.006; P<.0001), older age (adjusted odds ratio, 1.020; 95% confidence interval, 1.00-1.037; P=.015), greater body mass index (adjusted odds ratio, 1.04; 95% confidence interval, 1.01-1.07; P=.0006), American Society of Anesthesiologists 3 or 4 (adjusted odds ratio, 1.55; 95% confidence interval, 1.03-2.31; P=.03), and preoperative renal failure (adjusted odds ratio, 8.87; 95% confidence interval, 1.16-44.15; P=.04) remained significantly associated with developing venous thromboembolism. Neither laparoscopic repair (compared with vaginal repair) nor concurrent procedures (hysterectomy, antiincontinence procedure, vaginal mesh insertion) were found to be significantly associated with the development of venous thromboembolism. The abdominal pelvic organ prolapse repairs were associated with an increased hazard of venous thromboembolism (hazard ratio, 3.27; 95% confidence interval, 1.96-5.45; P<.0001). Venous thromboembolism development was associated with 30-day mortality, readmission, and reoperation (all P<.0001). CONCLUSION: The overall incidence of venous thromboembolism after pelvic organ prolapse repairs based on a recent, large cohort database was very low, confirming the finding in previous smaller cohort studies. The highest venous thromboembolism risk was associated with abdominal route, and more than 60% of venous thromboembolism events occurred within 10 days after surgery. Thus, focus should be placed on risk-reducing strategies in the immediate postoperative period, with greater emphasis on patients undergoing abdominal surgery.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Chong W, Bui AH, Menhaji K, et al. Incidence and risk factors for venous thromboembolism events after different routes of pelvic organ prolapse repairs. Am J Obstet Gynecol. 2020. PMID: 32413430. doi:10.1016/j.ajog.2020.05.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。